The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression: a Randomized Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 92
- 试验地点
- 2
- 主要终点
- Change from baseline in sleep efficiency (%) at follow-up assessed by polysomnography
研究概览
简要总结
The aim of this trial is to investigate the effects of a single bout of aerobic exercise on sleep in patients with depression.
详细描述
PRIMARY OBJECTIVE:
The primary objective of this study is to evaluate whether a single bout of aerobic exercise improves sleep efficiency more than a control condition in patients with depression.
SECONDARY OBJECTIVES:
Secondary objectives are to assess the effects of a single bout of aerobic exercise on 1) sleep continuity, 2) sleep architecture, 3) pre-sleep arousal, 4) subjective sleep quality, 5) daytime sleepiness, 6) nocturnal blood pressure, 7) heart rate variability, and 8) the frequency and severity of adverse events.
DESIGN:
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Inpatient psychosomatic rehabilitation in the clinic OBERWAID, St.Gallen, Switzerland
- •Age: ≥18 and ≤65 years old
- •Primary diagnosis of depression (F32, F33) without psychotic episode according to International Statistical Classification of Diseases, 10th edition
排除标准
- •Regular use of hypnotic agents (patients were included if no hypnotic agents were taken 2 weeks prior to study participation)
- •Factors precluding exercise testing or training
- •Use of beta-blockers (with the exception of Carvedilol & Nebivolol)
- •Use of opioids
- •History of epilepsy
- •Restless legs syndrome defined by ≥7 points on the restless legs syndrome screening questionnaire (RLSSQ)
- •Moderate or severe sleep apnea defined by an oxygen desaturation index (ODI) ≥15 in the first polysomnography.
- •Morbid adiposity with BMI >40
结局指标
主要结局
Change from baseline in sleep efficiency (%) at follow-up assessed by polysomnography
时间窗: Baseline (night 1) and follow-up (night 2)
Calculated as (total sleep time / total recording time) \* 100. Higher values represent a better outcome. A one-way ANCOVA will be computed with baseline sleep efficiency (%) and minimization factors as covariates, intervention as the independent variable, and follow-up sleep efficiency (%) as the dependent variable.
次要结局
- Change from baseline in number of awakenings at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
- Change from baseline in rapid eye movement sleep (% of total sleep time and minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
- Change from baseline in sleep onset latency (minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
- Change from baseline in nocturnal autonomic modulation at follow up(Baseline (night 1) and follow-up (night 2))
- Difference in adverse events between exercise and control group(Immediately after termination of exercise intervention or control condition and after awakening from follow-up (night 2))
- Change from baseline in stage 1 sleep (% of total sleep time and minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
- Change from baseline in stage 3 sleep (% of total sleep time and minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
- Change from baseline in non-rapid eye movement sleep (% of total sleep time and minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
- Change from baseline in stage shift index at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
- Change from baseline in wake after sleep onset (minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
- Change from baseline in light sleep (% of total sleep time and minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
- Change from baseline in rapid eye movement sleep-latency (minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
- Change from baseline in subjective sleep quality at follow-up assessed by self-rated questionnaire 'revised Schlaffragebogen A'(Baseline (night 1) and follow-up (night 2))
- Change from baseline in stage 2 sleep (% of total sleep time and minutes) at follow-up assessed by polysomnography(Baseline (night 1) and follow-up (night 2))
- Change from baseline in pre-sleep autonomic modulation at follow-up(Baseline (night 1) and follow-up (night 2))
- Change from baseline in post-sleep autonomic modulation at follow-up(Baseline (night 1) and follow-up (night 2))
- Change from baseline in nocturnal mean arterial pressure at follow-up assessed by pulse transit time (ECG, modified lead II; fingertip photoplethysmogram, single initial calibration measurement)(Baseline (night 1) and follow-up (night 2))
- Change from baseline in subjective pre-sleep arousal at follow-up assessed by self-rated questionnaire 'Pre-Sleep Arousal Scale'(Baseline (night 1) and follow-up (night 2))
- State sleepiness assessed by self-rated questionnaire 'Stanford Sleepiness Scale' (SSS)(Day 5 (i.e. day after night 2): at 08:00 am, 12 noon, 04:00 pm, and 08:00 pm)
